genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2008
Wyeth Pharmaceuticals
News
Profectus BioSciences Awarded $21.6M from NIAID to Develop HIV Vaccines
News
Profectus Receives Preclinical Portfolio of Vaccines from Wyeth
News
Wyeth Inks $100M Pact for Advanced Life Sciences’ Late-Stage Antibiotic in Asia Pacific Region
News
Trubion Pharmaceuticals and Wyeth Lengthen Collaboration
News
Progenics and Wyeth Obtain FDA Nod for Drug to Treat Opioid-Induced Constipation
News
Wyeth Nixes CNS Deal with Solvay
News
FDA Gives the Go-Ahead to Wyeth for Hemophilia A Therapy and Abbott for JIA Drug
Insights
Trubion Tackles Second-Generation mAbs
News
Akrimax Purchases Wyeth’s Rouses Point Facility
News
Ablynx Extends Agreement with Wyeth for One Year
1
2
3
4
Page 2 of 4
Scroll Up
Scroll Up
